[ALA] QoQ Quarter Result on 31-Mar-2020 [#Q3]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Mar-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q3]
Profit Trend
QoQ- 85.48%
YoY- 67.71%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 243 176 163 106 370 192 396 -27.68%
PBT -1,756 -874 -2,892 -1,446 -7,699 -3,850 -7,850 -62.98%
Tax -9 0 -656 -328 0 0 -925 -95.37%
NP -1,747 -874 -2,236 -1,118 -7,699 -3,850 -6,925 -59.90%
Tax Rate - - - - - - - -
Total Cost 1,990 1,050 2,399 1,224 8,069 4,041 7,321 -57.87%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -720.44 -496.92 -1,372.98 -1,053.37 -2,081.94 -2,008.97 -1,748.22 -44.47%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.01 -0.00 -0.01 -0.01 -0.05 -0.03 -0.04 -60.14%
EPS Diluted -0.01 -0.00 -0.01 -0.01 -0.05 -0.03 -0.04 -60.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.